SUPAR AND OSTEOPONTIN CIRCULATING LEVELS IN LUPUS NEPHRITIS: ARE THEY EARLY MARKERS OF PODOCYTE DAMAGE

被引：0
|
作者：
Quaglia, Marco [1 ]
Musetti, Claudio [1 ]
Clemente, Nausicaa [2 ]
Chiocchetti, Annalisa [2 ]
Dianzani, Umberto [2 ]
Stratta, Piero [1 ]
机构：
[1] Univ Piemonte Orientale, Dept Translat Med Nephrol & Kidney Transplant, Novara, Italy
[2] Univ Piemonte Orientale, Dept Hlth Sci, Immunol Lab, Novara, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv188.81
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP118
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PODOCYTE DAMAGE BY AUTOANTIBODIES IN LUPUS NEPHRITIS
    Hillmann, A.
    Jung, E.
    Wardemann, H.
    Pap, T.
    Jacobi, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 525 - 526
  • [2] IS CIRCULATING SUPAR A POTENTIAL BIOMARKER OF LUPUS NEPHRITIS IN CHILDREN WITH NEPHROTIC PROTEINURIA?
    Soltysiak, Jolanta
    Silska-Dittmar, Magdalena
    Ostalska-Nowicka, Danuta
    Lewandowska-Stachowiak, Maria
    Zachwieja, Jacek
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [3] SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
    Zhao, Xin-yu
    Li, Shuang-shuang
    He, Ying-xin
    Yan, Li-jie
    Lv, Fu
    Liang, Qi-meng
    Gan, Yu-hui
    Han, Li-pei
    Xu, Hong-de
    Li, Yong-chun
    Qi, Yuan-yuan
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) : 1328 - 1340
  • [4] Endothelial dysfunction and circulating markers of endothelial damage in systemic lupus erythematosus
    Shevchuk, SV
    Stanislavchuk, MA
    Zaichko, NV
    RHEUMATOLOGY, 2005, 44 : I140 - I140
  • [5] Correspondence on: ?SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy'
    Soler, Maria Jose
    Cacha, Conxita Jacobs
    Anders, Hans-Joachim
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (06) : e13 - e13
  • [6] Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus
    Rullo, Ornella J.
    Woo, Jennifer M. P.
    Parsa, Miriam F.
    Hoftman, Alice D. C.
    Maranian, Paul
    Elashoff, David A.
    Niewold, Timothy B.
    Grossman, Jennifer M.
    Hahn, Bevra H.
    McMahon, Maureen
    McCurdy, Deborah K.
    Tsao, Betty P.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (01)
  • [7] Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus
    Ornella J Rullo
    Jennifer MP Woo
    Miriam F Parsa
    Alice DC Hoftman
    Paul Maranian
    David A Elashoff
    Timothy B Niewold
    Jennifer M Grossman
    Bevra H Hahn
    Maureen McMahon
    Deborah K McCurdy
    Betty P Tsao
    Arthritis Research & Therapy, 15
  • [8] Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels Reflect Organ Damage in Systemic Lupus Erythematosus
    Enocsson, Helena
    Wettero, Jonas
    Skogh, Thomas
    Sjowall, Christopher
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S267 - S268
  • [9] THE ROLE OF MONOCYTES IN KIDNEY DAMAGE-CELLULAR MARKERS AND THERAPEUTIC TARGETS IN LUPUS NEPHRITIS?
    Stamatiades, E.
    Jordan, N.
    Carlin, L.
    Woollard, K.
    Geissmann, F.
    INFLAMMATION RESEARCH, 2011, 60 : 187 - 187
  • [10] ANTI-CIQ ANTIBODY LEVELS ARE NOT RELIABLE FORECASTERS OR MARKERS AND LUPUS NEPHRITIS FLARE
    Bitter, Joshua E.
    Rovin, Brad H.
    Hebert, Lee A.
    Birmingham, Daniel J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A45 - A45
12345